Parkinson's Disease Treatment Guide for Physicians

by Ahlskog, MD, PhD, J. Eric

• ISBN13: 9780195371772
• ISBN10: 0195371771
• Edition: 1st
• Format: Hardcover
• Copyright: 2009-03-25
• Publisher: Oxford University Press

Summary

Roughly 1.9 million people are afflicted with Parkinson's disease and, according to the Parkinson's Disease Foundation, that number is on the rise! Parkinson's Disease Treatment Guide for Physicians will comprehensively cover Parkinson's disease (PD), including diagnosis, testing, prognosis, and possible causes. Its primary focus will be on treatment, specifying appropriate drugs, doses, and common side effects. It will address not only the treatment of motor problems (tremor, gait, etc.), but everything else that routinely arises in a PD practice, including osteoporosis prevention, blood pressure, sexual, bowel, or bladder dysfunction, dementia, depression, common skin rashes, and more. This book will mirror Dr. Ahlskog's earlier book, The Parkinson's Treatment Book: Partnering with Your Doctor to Get the Most from Your Medications (2005). Each chapter in the current book will follow the same outline and cover nearly the same material as in each chapter of the earlier patient book, but it will be more succint and direct, with many teaching points summarized wtih bullet points or in small tables. In effect, the clinician and patient can both be reading, or have read, the same material.

Table of Contents

Acknowledgments	p. xi
Background	p. 3
Clinical Basics: Understanding and Examining the Motor System	p. 6
Basic Neuropathology and Neuroanatomy of Parkinson's Disease	p. 13
Clinical Diagnosis of Parkinson's Disease	p. 20
Natural Progression of Parkinson's Disease over the Lifetime	p. 28
Conditions Mistaken for Parkinson's Disease	p. 35
Efficient Testing, Including Brain Imaging	p. 56
Etiology and Epidemiology of Parkinson's Disease	p. 59
Strategies for Slowing Parkinson's Disease Progression	p. 73
Overview: Available Drugs for Motor Problems of Parkinson's Disease	p. 79
Choosing the Initial Drug (Confronting Controversies)	p. 105
Starting Treatment with Carbidopa/Levodopa	p. 116
Starting Treatment with a Dopamine Agonist Drug	p. 136
Parkinsonism-Plus Syndromes, Levodopa Failures, and Refractory Tremor: Treatment Options	p. 151
Problems That May Surface during the First Few Years of Levodopa Treatment	p. 160
When a Dopamine Agonist Is the First and Primary Drug: Early Problems	p. 164
Levodopa Adjustments to Treat Motor Instability: Motor Fluctuations and Dyskinesias	p. 170
Adjunctive Drugs for Motor Fluctuations and Dyskinesias	p. 189
Nonmotor Symptoms Requiring Dopamine Replacement Therapy	p. 206
Insomnia, Somnolence, and Other Sleep Disorders	p. 214
Orthostatic Hypotension and Other Causes of Dizziness	p. 230
Depression	p. 241
Dementia	p. 246
Hallucinations, Delusions, and Pathologic Behaviors	p. 254
Dysphagia, Drooling, and Dysarthria	p. 270
Constipation and Delayed Gastric Emptying	p. 274
Urinary Symptoms	p. 279
Sexual Dysfunction, Estrogen, and Menstrual Cycles	p. 287
Other Common Problems: Edema, Rashes, and Visual Symptoms	p. 293
Diets, Nutrition, and Osteoporosis Prevention	p. 301
Exercise, Physical Therapy, and an Active Lifestyle	p. 308
Societal and Occupational Issues; Caregivers	p. 315
Surgery: Nonneurologic and Parkinson's Disease Operations, Including Deep Brain Stimulation	p. 320
Future Parkinson's Disease Treatment: Directing Resources and Counseling Patients	p. 336
Clinical Rating Scales and Patient Resources	p. 343
Author Index	p. 362
Subject Index	p. 374
Table of Contents provided by Ingram. All Rights Reserved.